Frédéric Leduc

Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA.

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada.

Césart Création, Inc. is a Canadian company that provides business consulting, marketing services, computerized animation, and integrated software and applications. The company was founded by Yves Eric Laliberté and is based in Montréal, Canada. Part of BCE, Inc., Césart Création, Inc. offers a range of services to help businesses with their marketing and software needs. Césart Création, Inc. was acquired by Bell Zinc Corp on December 01, 2001.

Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada.

Léger Robic Richard LLP is a private company based in Montréal, Canada.

Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA.

Triton Digital, Inc. provides digital audio technology for the audio industry. Its solutions include podcasting, audio streaming, audio advertising, audience measurement, and audience engagement. The company was founded by Michael Agovino and Neal Schore in 2006 and is headquartered in Sherman Oaks, CA.

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.

Réseau Capital operates as a venture capital and private equity association. It promotes private equity industry in Quebec through training, information and promotion, networking, and representation. The company was founded by Jean-Pierre Chartrand in 1989 and is headquartered in Montréal, Canada.

Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada.

Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada.

Gestion Univalor LP Provides research services. Its services include researcher services, and industry and investors services. The company was founded in 2001 and is headquartered in Montreal, Canada.

StreamTheWorld, Inc. provides Internet streaming solutions for audio and video content. Its integrated streaming solutions enable radio and television broadcasters generate record online revenues. The company was founded in 2005 and is headquartered in Montréal, Canada.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Association des MBA de Québec develops a network for students and graduates. The company is headquartered in Montreal, Canada.

Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada.

Triton Digital Media provides digital audio technologies and advertising platforms. The company was founded by Neal Schore and Michael Agovino in 2006 and is headquartered in Sherman Oaks, CA.

Aptalis Pharma SAS is engaged in manufacturing pharmaceutical preparations. Its products include zenpep, canasa, carafate, pylera, rectiv, viokace, ultresa lacteol, delursan, panzytrat and salofalk. The company was founded in 1982 and is headquartered in Courbevoie, France.

Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada.

TransferTech Sherbrooke manages research intellectual property. It provides protection, exploitation and valorization of research results. The firm also applies valuation strategies to commercialize technologies, either as licenses or spin-off businesses. The company was founded in January 2007 and is headquartered in Sherbrooke, Canada.

Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada.

Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada.

H&P Labs, Inc. operates as a biotechnology firm. It develops drugs to fight infectious viral diseases for public health and biodefense missions. The company was founded by John Michel T. Huss on June 7, 2013 and is headquartered in Westmount, Canada.

Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada.

Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.

Part of Charles River Laboratories International, Inc., Charles River Laboratories Montreal ULC provides clinical laboratory services.

ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013.

Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada.